Bone marrow aplasia associated to the use of ticlopidine

Autor: Ruiz B, Carolina, Monroy A, Tatiana, Montaña N, Nelson, Lora L, Pilar, Lamich B, Rubén, Valderrama R, Alejandro
Jazyk: Spanish; Castilian
Rok vydání: 2002
Předmět:
Zdroj: Revista médica de Chile, Volume: 130, Issue: 7, Pages: 798-802, Published: JUL 2002
Popis: We report a 58 years old male that developed a bone marrow aplasia associated to the use of ticlopidine, prescribed after coronary artery stenting. The patient developed a pneumonia as a complication. He was admitted to the Intermediate Treatment Unit, receiving wide spectrum antimicrobial therapy and a granulocyte colony stimulating factor (Neupogen(r)) with favourable response. Ticlodipine is an effective anti-platelet agent, but has serious hematological and other side effects. Its prescription requires a close follow up and search for complications (Rev Méd Chile 2002; 130: 798-802).
Databáze: OpenAIRE